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Abstract
Background: Evidence-based medicine posits that health care research is founded upon clinically
important differences in patient centered outcomes. Statistically significant differences between
two treatments may not necessarily reflect a clinically important difference. We aimed to quantify
the sample sizes and magnitude of treatment effects in a review of orthopaedic randomized trials
with statistically significant findings.
Methods: We conducted a comprehensive search (PubMed, Cochrane) for all randomized
controlled trials between 1/1/95 to 12/31/04. Eligible studies include those that focused upon
orthopaedic trauma. Baseline characteristics and treatment effects were abstracted by two
reviewers. Briefly, for continuous outcome measures (ie functional scores), we calculated effect
sizes (mean difference/standard deviation). Dichotomous variables (ie infection, nonunion) were
summarized as absolute risk differences and relative risk reductions (RRR). Effect sizes >0.80 and
RRRs>50% were defined as large effects.
Using regression analysis we examined the association between the total number of outcome
events and treatment effect (dichotomous outcomes).
Results: Our search yielded 433 randomized controlled trials (RCTs), of which 76 RCTs with
statistically significant findings on 184 outcomes (122 continuous/62 dichotomous outcomes) met
study eligibility criteria. The mean effect size across studies with continuous outcome variables was
1.7 (95% confidence interval: 1.43–1.97). For dichotomous outcomes, the mean risk difference was
30% (95%confidence interval:24%–36%) and the mean relative risk reduction was 61% (95%
confidence interval: 55%–66%; range: 0%–97%). Fewer numbers of total outcome events in studies
was strongly correlated with increasing magnitude of the treatment effect (Pearson's R = -0.70, p
< 0.01). When adjusted for sample size, the number of outcome events revealed an independent
association with the size of the treatment effect (Odds ratio = 50, 95% confidence interval: 3.0–
1000, p = 0.006).
Conclusion: Our review suggests that statistically significant results in orthopaedic trials have the
following implications-1) On average large risk reductions are reported 2) Large treatment effects
(>50% relative risk reduction) are correlated with few number of total outcome events. Readers
should interpret the results of such small trials with these issues in mind.
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Evidence-based medicine posits that health care research
is founded upon clinically important differences in
patient centered outcomes. Randomized trials continue to
represent the reference standard for the comparison of
surgical interventions [1-4]. Although fundamentally the
most important for guiding clinical practice, few rand-
omized trials are conducted in orthopaedic surgery. Cur-
rent estimates suggest that less than 5% of the orthopaedic
literature represent randomized trials [5-7]. Nevertheless,
the impact of randomized trials, especially those with sta-
tistically significant findings, is large [8].
Statistically significant differences between two treat-
ments may not necessarily reflect a clinically important
difference. Although it is well known that orthopaedic
studies with small sample sizes risk underpowered false
negative conclusions (Beta-errors) [6,9,10], statistically
significant findings in small trials can occur at the conse-
quence of very large differences between treatments (treat-
ment effect). It is not uncommon for randomized trials to
report relative risk reductions larger than 50% when com-
paring one treatment with another [11-13].
Devereaux and colleagues caution the interpretation of
small trials in cardiology [14]. For example, the peri-oper-
ative beta-blocker evidence suggests large treatment effects
(i.e., relative risk reductions >75%) but these results are
inconsistent with beneficial cardiovascular therapies
established in trials with 10,000s of patients, which gen-
erally demonstrate moderate relative risk reductions in
the order of 15 to 35% [14-16].
Our study had 2 objectives: 1) To determine the magni-
tude of treatment effects in a sample of orthopaedic rand-
omized trials with statistically significant results and 2) to
examine the association between the number of outcome
events (a measure of study sample size) and the size of the
treatment effect. We conducted a systematic review to
identify randomized trials in orthopaedic trauma with the
following hypotheses: 1) statistically significant studies
would not always report large treatment effects and 2)
studies with smaller sample sizes (and few outcome
events) would be more likely to report larger treatment
effects than those with larger sample sizes.
Methods
Eligibility Criteria
We included studies which met the following eligibility
criteria: 1) published studies, 2) described as randomized
trial, 3) involve the care of adult patients with fractures,
either operative or conservative, 4) published in English
and 5) contain sufficient outcomes information to calcu-
late treatment effects for both dichotomous and continu-
ous outcome measures. Our decision to focus upon
trauma randomized trials was based upon two factors: 1)
allowing comparison with previous studies evaluating
this population of trials, and 2) practicality of limiting the
number of trials to a sufficiently manageable number to
optimize the efficiency of study completion and research
resource utilization within our Departments.
Study Identification
We conducted a comprehensive search (PubMed,
Cochrane database) for all randomized controlled trials
between January 1, 1995 and December 31,2004. We
used the search terms "randomized controlled trial" and
"fracture" and "surgery" with limits (adults 19+ years).
The eligibility criteria were applied to potentially eligible
study titles by two independent reviewers (JS, MB). One of
the two reviewers was trained in health research method-
ology, while the other was an orthopaedic resident.
Abstracts for those eligible study titles were retrieved by
one of us. Following a second application of eligibility cri-
teria to abstracts by independent reviewers, complete cita-
tions for those potentially eligible studies were retrieved.
The methods section of each retrieved citation was
reviewed by two of us to ensure all inclusion criteria were
met. In addition to Medline searches, two of us performed
a search of the NIH PubMed computerized database and
one of us conducted a Cochrane Database search. For
both searches, we used "fractures" and "randomized tri-
als" as keywords.
Additional strategies to identify relevant citations
included: 1) hand searches of the table of contents over
the past 5 years of the Journal of Orthopaedic Trauma,
Journal of Trauma, Clinical Orthopaedics and Related
Research and Acta Orthopaedica Scandinavica, 2) review
of the reference lists of eligible (included) studies to iden-
tify other potentially eligible studies, and 3) content
experts' (traumatologist) review of the list of eligible stud-
ies to identify any missing studies.
Characteristics of Eligible Studies
Two reviewers independently abstracted general charac-
teristics of each eligible study. These included, first author
(surgeon/non-surgeon), geographic location, category of
intervention, body region of focus (upper extremity, lower
extremity, spine), number of participating centres, and
funding (yes/no).
Determination of Treatment Effects and Outcome Events
For dichotomous outcome measures (ie re-operation,
infection), we calculated relative risks as percent (%) re-
operation intervention group divided by percent (%) re-
operation in comparison group. For ease of interpretation
we converted relative risks to relative risk reductions [(1-
Relative Risk) × 100]. We also calculated absolute risk dif-
ferences. A relative risk reduction of 50% was interpretedPage 2 of 13
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outcome event by 50% compared to a control (compari-
son treatment).
For continuous outcome measures (ie functional scores)
we calculated an effect size as described by Cohen [17].
'Effect Size' is simply a way of quantifying the effectiveness
of a particular intervention, relative to some comparison.
It is easy to calculate, readily understood and can be
applied to any measured outcome in surgical trials. It is
the standardized mean difference between the two
groups. We used the following formula for its calculation:
For example, an effect size of 0.8 means that the score of
the average person in the experimental group exceeds the
scores of 79% of the comparison group. Cohen describes
an effect size of 0.2 as 'small' and gives to illustrate it the
example that the difference between the heights of 15 year
old and 16 year old girls in the US corresponds to an effect
of this size. An effect size of 0.5 is described as 'medium'
and is 'large enough to be visible to the naked eye'. A 0.5
effect size corresponds to the difference between the
heights of 14 year old and 18 year old girls. Cohen
describes an effect size of 0.8 as 'grossly perceptible and
therefore large' and equates it to the difference between
the heights of 13 year old and 18 year old girls [17]. For
each study, we documented outcomes measured deemed
primary by the study authors. In cases in which primary
outcomes were not specified by authors, two of us
(trained orthopaeidic surgeons) made judgments about
the key outcomes based upon the study interventions.
Assessing Reviewer Agreement
Agreement in the application of study eligibility criteria,
identification of study outcomes and study results (posi-
tive or negative) was quantified with the Kappa statistic
with quadratic weighting. The kappa statistic, a measure
of the agreement between two or more individuals
beyond chance, provided a measure of agreement among
reviewers for titles, abstracts and methods sections of
potentially relevant. In the context of inter-observer agree-
ment studies, Fleiss and Donner provide persuasive argu-
ments favoring the use of this statistic over other measures
of agreement that have been proposed [18,19].
Data Analysis
We presented descriptive statistics about continuous vari-
ables with means, standard deviations and dichotomous
variables as proportions. We calculated relative risks and
95% confidence intervals to describe treatment effects and
compared relative risks in studies with few and many
events with tests for interaction. Logistic regression pro-
vided methods for estimating the extent of association
between the total number of events (ie, endpoints driving
termination) in the trial and the calculated treatment
effect. We categorized the number of outcome events as
follows: 1) 0–25 events, 2) 26–50 events, 3) 51–75
events, and 4) 76–100 events. We also categorized studies
as having a relative risk reduction as follows: 1) <50% and
2)>50%. We expressed any associations using odds ratios
(ORs) and associated 95% confidence intervals (CIs).
Analyses were performed using SPSS version 13.0. We
conducted a correlation analysis of the number of out-
come events against the treatment effect with a Pearson's
R. We considered P < 0.05 as the level of statistical signif-
icance for all comparisons. All tests were two- tailed.
Results
Literature Search
We identified 433 potentially relevant study titles from
the MEDLINE database search. (Figure 1). Application of
the study eligibility criteria eliminated 171 titles, leaving
262 for further consideration (Table 1). Following com-
plete review of 262 study abstracts, 94 were excluded,
leaving 168 papers. In total, 168 studies appeared poten-
tially eligible from study title and abstract alone and full
manuscripts were retrieved for a detailed review. Agree-
ment in the application of eligibility criteria to study titles
and abstracts was substantial (Kappa = 0.80, 95% confi-
dence interval: 0.74–0.86). Application of the eligibility
criteria to the complete manuscripts of 168 trials elimi-
nated 92 studies (Table 1). Thus, 76 papers that met all
apriori eligibility criteria were included in the analyses
(Appendix).
Study Characteristics
The 76 eligible trials were published across 9 different
journals (Table 2). The majority of studies were published
in Journal of Orthopaedic Trauma (21%), JBJS-British
(18%), and JBJS-American (13%). Most of the studies
were conducted in Europe (58%) followed by North
America (32%) (Table 3). Seventy-three (96%) of the first
authors were surgeons and the majority of studies were
single center initiatives (83%). Funding for the conduct of
the trial was reported in 17 studies (22%). A total of 9757
patients were randomized in the 76 trials. Moreover,
study sample sizes ranged from 10 to 424 patients (mean
= 77 patients, st.dev = 69).
Treatment Effects
We identified 62 dichotomous outcomes across our sam-
ple of 76 studies (Table 4). The mean sample size in stud-
ies that reported dichotomous outcomes was 81.2 ± 61.4
patients (median 55 patients) with a minimum 14
patients to a maximum 250 patients. For dichotomous
outcomes, the mean risk difference was 30% (95%confi-
dence interval:24%–36%; range 2%–138%). The treat-
ment effects (relative risks) averaged 0.39 (95%
Effect Size =
[Mean of  experimental group]-[Mean of  Comparison group]
Pooled Standard DeviationPage 3 of 13
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translated to a mean observed relative risk reduction of
61% (95% confidence interval: 55%–66%; range: 0%–
97%). Thus, the average study reported large reductions
(>50% relative risk reduction) in the risk of an adverse
outcome event versus a comparative treatment; however,
almost 1 in 2 study outcomes (47%) had RRRs<50%, and
over 1 in 5 (23%) had RRRs<20%.
We identified 122 continuous outcomes across our sam-
ple of 76 studies (Table 4). The mean sample size in stud-
ies reporting continuous outcomes was 70 ± 69 patients
(median = 50 patients) with a minimum 10 patients and
a maximum 424 patients. The absolute mean difference
between treatments was 81.2 (95% confidence interval:
49.2–113.2). The effect size averaged 1.7 (95% confi-
dence interval: 1.43–1.97). Eighty four outcomes reported
(69%) large effect sizes (ES>0.80).
Association between Treatment Effect and the Number of 
Outcome Events
The mean number of outcome events (Treatment group +
Comparison Group) across studies with dichotomous
outcomes was 24 ± 21 (median = 17). The total number
of outcome events ranged from 1 event to 90 events.
Fewer numbers of total outcome events in studies was
strongly correlated with increasing magnitude of the treat-
ment effect (Pearson's R = -0.70, p < 0.01) (Figure 2). The
relative risk reduction decreased as the number of out-
come events increased from 0–25 events to 75–100 events
(Rel. Risk Red = 73% vs 16%, respectively, P < 0.01)
(Table 5) (Figure 3). In the logistic regression analysis,
fewer than 50 outcome events was significantly associated
with a relative risk reduction greater than 50% (Odds ratio
= 21, 95% confidence interval: 2.1–200, p = 0.0–09).
When adjusted for sample size, the number of outcome
events continued to show independent association with
the size of the treatment effect (Odds ratio = 50, 95% con-
fidence interval: 3.0–1000, p = 0.006). The number of
outcome events explained 32% of the variance in the
regression model. In the 6 studies with greater than 50
total outcome events, 5 studies had modest to small rela-
tive risk reductions range (3%–33%).
Discussion
Our review of trials with statistically significant findings in
orthopaedic trauma suggests the following: 1) trials have
Literature searchFigure 1
Literature search.
 PubMed Search
Identified
433 Papers
Papers eligible for study 
262 Papers 
Excluded after review of titles 
171 Papers 
Papers eligible for study 
168 Papers 
Excluded after review of abstracts 
94 Papers 
Papers eligible for study 
76 Papers 
Excluded after review of paper 
92 Papers 
Table 1: Reasons for Study Exclusion (N = 96 excluded) from Full Manuscript Review
Reason for Exclusion Number
I. Reasons for Study Exclusion (N = 171 excluded) from Title Review
Medical Interventions 50
Anesthesia Papers 46
OMFS/ENT/Ophthalmology/Dental 22
Rehabilitation Paper 13
DVT Papers 6
Antibiotic Papers 6
Nutrition Papers 4
Miscellaneous 34
II. Reasons for Study Exclusion (N = 92 excluded) from Full Manuscript Review
No data available 36
Non-English Journal 24
Insufficient Data to Calculate Effect Sizes 16
Journal Unobtainable 6
Not Statistically Significant Data 4
Medical Interventions 2
Non trauma Spine 1
Non trauma Sports 1
Rehabilitation Paper 1
Retrospective Paper 1Page 4 of 13
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and 3) large treatment effects (>50% relative risk reduc-
tion) correlated with fewer number of total outcome
events. Readers should interpret the results of such small
studies with few events with caution.
Strengths and Limitations
Our study is strengthened by a comprehensive literature
review including hand searches of major orthopaedic
journal, careful study methodology and duplicate data
abstraction. Our search strategy, although comprehensive
may have missed studies related to fracture care due to
errors in study indexing in Medline or those articles not
indexed in PubMED. Our decision to identify only trials
relating to orthopaedic trauma for pragmatic reasons lim-
its our generalizability beyond this subspecialty. How-
ever, it remains plausible that the associations we
observed are consistent throughout the orthopaedic liter-
ature in both English and Non-English trials. The lack of
reporting of sufficient data to calculate treatment effect
size for those studies with continuous outcome variables
was another limitation. Fifty-two studies were excluded
for this reason. We realize that excluding so many studies
is a limitation. However, review of these studies suggests
that they were similar in sample size, geographic location,
funding status and number of centers to our included
studies.
Relevant Literature Review
Whereas statistical significance means the likelihood that
the difference found between groups could have occurred
by chance alone, effect-sizes provide an estimate of the
size of the treatment effect. Effect sizes are important
because they facilitate the comparison of treatment effects
across different studies. In most clinical trials, a result is
statistically significant if the difference between groups
could have occurred by chance alone in less than 1 time in
20 (i.e. less than 5% probability, p < 0.05). A trivial differ-
ence can have a low p value (i.e. much less than p < 0.05)
if the sample size of the study is large. For example, a large
trial (N = 7601 patients) comparing the use effects of the
angiotensin receptor blocker candesartan on cardiovascu-
lar outccomes reported a significant reduction in the
development of atrial fibrillation with candesartan versus
placebo (p = 0.048); however, the actual difference was
1.19% (6.74% vs 5.55%, respectively) [20].
The findings reported in some biomechanical studies
should also be interpreted cautiously. For example, a bio-
mechanical study that compared the compression effect of
the 7.0-AO screw and the 6.5 mm Ideal Compression
Screw (I.CO.S.) screw in an in vitro subtalar arthodesis
model. The authors reported that the AO screw led to a
significantly increased mean contact force (p < 0.05);
however, this increase was 7.6 N – the clinical significance
of which is completely uncertain [21].
Clinical significance is a matter of judgment. However,
clinically significant findings imply that the difference
between treatment groups are large enough to be impor-
tant to patients. We can argue that an absolute difference
of 1.19% is not a clinically important difference. Alterna-
tively, a study of 50 patients reporting a 20% (10/25, 40%
vs 5/25, 20%, p = 0.12) absolute difference in atrial fibril-
lation rates between candesartan and placebo groups may
be more compelling for clinical practice. However, the dif-
ference may not reach statistical significance.
There have been no studies in the surgical literature eval-
uating the association of treatment effect magnitudes and
number of outcome events. However, investigators have
examined inflated treatment effects in large medical trials
stopped early for benefit at an early interim analysis [16].
For example, a trial that aimed to recruit 1000 patients
may be terminated early if an interim analysis of 100
patients shows a very large benefit of the treatment over a
comparison (ie relative risk reduction >50%). The deci-
sion to terminate a trial before it reaches its preplanned
Table 2: Literature Search – Journals for 76 Included Articles
Journal Title # of Articles
Acta Orthopaedica Scandinavica 8
Journal of Bone and Joint Surgery – British Volume 14
Clinical Orthopaedics and Related Research 9
Injury 5
Journal of Bone and Joint Surgery – American Volume 10
Journal of Orthopaedic Trauma 16
Journal of Trauma 8
Journal of Hand Surgery – British Volume 4
Foot and Ankle International 2
Total 76Page 5 of 13
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Characteristics No. of 
Studies 
(Percent)
JOT JBJS-
Am
JBJS-
Br
CORR Acta Orth. 
Scand
Journal of 
Trauma
Injury Foot and 
Ankle 
Internat.
Journal 
Hand-Br.
1. First Author:
Surgeon: 73/76 
(96.0%)
15/16 10/10 13/14 8/9 8/8 8/8 5/5 2/2 4/4
Non-Surgeon: 3/76 (4%) 1/16 0/10 1/14 1/9 0/8 0/8 0/5 0/2 0/4
Epidemiologist: 0 (0%) 0/16 0/10 0/14 0/9 0/8 0/8 0/5 0/2 0/4
2. Epidemiology Affiliation:
Yes: 16/76 
(21.0%)
0/16 2/10 10/14 0/9 1/8 3/8 0/5 0/2 0/4
No: 60/76 
(78.9%)
16/16 8/10 4/14 9/9 7/8 5/8 5/5 2/2 4/4
3. Geographical Location:
North America: 24/76 (32%) 9/16 6/10 1/14 5/9 0/8 2/8 0/5 1/2 0/4
Europe (includes 
England):
44/76 (58%) 7/16 4/10 10/14 4/9 8/8 2/8 4/5 1/2 4/4
Australia or New 
Zealand:
1/76 (1.%) 0/16 0/10 1/14 0/9 0/8 0/8 0/5 0/2 0/4
Asia: 6/76 (8%) 0/16 0/10 2/14 0/9 0/8 3/8 1/5 0/2 0/4
Israel: 1/76 (1%) 0/16 0/10 0/14 0/9 0/8 1/8 0/5 0/2 0/4
4. Category of 
Intervention:
Fracture Treatment: 70/76 
(92.1%)
16/16 9/10 12/14 8/9 7/8 7/8 5/5 2/2 4/4
Other Treatment: 5/76 (6.6%) 0/16 1/10 1/14 1/9 1/8 1/8 0/5 0/2 0/4
Vascular Treatment: 1/76 (1.3%) 0/16 0/10 1/14 0/9 0/8 0/8 0/5 0/2 0/4
5. Region of Body:
Upper Extremities: 16/76 
(21.0%)
2/16 5/10 2/14 0/9 0/8 1/8 2/5 0/2 4/4
Lower Extremity 
Long Bones:
23/76 
(30.3%)
9/16 1/10 4/14 2/9 1/8 5/8 1/5 0/2 0/4
Spine: 2/76 (2.6%) 0/16 1/10 0/14 1/9 0/8 0/8 0/5 0/2 0/4
Hip: 28/76 
(36.8%)
4/16 2/10 6/14 6/9 6/8 2/8 2/5 0/2 0/4
Foot and Ankle 4/76 (5.3%) 0/16 1/10 0/14 0/9 1/8 0/8 0/5 2/2 0/4
Knee: 2/76 (2.6%) 1/16 0/10 1/14 0/9 0/8 0/8 0/5 0/2 0/4
Upper and Lower 
Extremity:
1/76 (1.3%) 0/16 0/10 1/14 0/9 0/8 0/8 0/5 0/2 0/4
6. Single or Multicentred:
Single: 63/76 (83%) 15/16 6/10 13/14 6/9 5/8 8/8 5/5 2/2 3/4
Multicentred: 13/76 (17%) 1/16 4/10 1/14 3/9 3/8 0/8 0/5 0/2 1/4
7. Funding:
Yes: 17/76 (22%) 2/16 4/10 4/14 2/9 4/8 0/8 0/5 0/2 1/4
No: 27/76 (36%) 10/16 4/10 10/14 1/9 0/8 0/8 1/5 0/2 1/4
Unknown: 32/76 (42%) 4/16 2/10 0/14 6/9 4/8 8/8 4/5 2/2 2/4
* JBJS = Journal of Bone and Joint Surgery, JOT = Journal of Orthopaedic Trauma; CORR = Clinical Orthopaedics and Related Research
sample size is based upon apriori statistical stopping rules
(threshold of a p value is reached). If we extrapolate this
to orthopaedic surgical trials, we can conceptualize these
small trials (mean = 80 patients) with large treatment
effects (relative risk reductions of >66%) as trials that were
essentially "stopped early". In doing so, the same play of
chance positive findings can be extrapolated to this litera-
ture. Moreover, implications of stopped early trials can be
explored from previous reports in the medical literature.Page 6 of 13
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with large treatment effects exist in the literature [15,16].
For example, the preliminary results of the twelfth Medi-
cal Research Council acute myeloid leukemia trial ulti-
mately revealed no evidence of a survival advantage for
five courses of therapy compared to four courses in a ran-
domized comparison involving 1078 patients (hazard
ratio 1.09, 95% confidence interval [CI] 0.87–1.37, p =
0.4) [15]. However, large benefits of the 5 course therapy
(53% and 45% reductions in the odds of death) in early
interim analyses of fewer patients recruited were fortu-
nately dismissed as "too good to be true" and implausible.
The ultimate large trial prevented the wide adoption of a
non-beneficial therapy with potential harms of more
chemotherapy.
Another poignant example of the pitfalls of small trials
and large effects is derived from Cardiology – the case of
magnesium in acute myocardial infarction [22,23]. When
initial small trials have claimed remarkably large benefits,
subsequent trials typically demonstrated much more
modest. For example, a meta-analysis of RCTs of magne-
sium in acute myocardial infarction demonstrated a statis-
tically significant (P < 0.001) > 50% reduction in death
with approximately 1,500 patients randomized [20].
However, the subsequent RCT of approximately 60,000
patients showed no benefit; in fact there was a trend
toward excess mortality with magnesium (P = 0.07) [23].
Devereaux and colleagues argue that cardiovascular thera-
pies rarely demonstrate relative risk reductions greater
than 35%, because cardiovascular therapies usually only
target a limited number of the multitude of pathogenic
mechanisms underlying cardiovascular diseases, as is the
case with peri-operative beta-blockers [24].
Take, for example, the RCT evaluating the efficacy of biso-
prolol (Beta-blocker) in patients with a positive dob-
utamine echocardiography result and undergoing elective
vascular surgery [25]. The trial was stopped when investi-
gators had enrolled 112 patients of the pre-planned 266
patients. The relative risk reduction for the primary out-
come (cardiac death or nonfatal myocardial infarction)
was 91% (95% CI, 63%–98%). This very large treatment
effect is implausible given that the authors anticipated a
less beneficial effect of this drug. In fact, a subsequent trial
of larger sample size and greater outcome events (496
patients) undergoing vascular surgery that reported no
significant effect of Beta-blockers on cardiac death or non-
fatal myocardial infarction [26].
Montori and colleagues recently conducted a systematic
review to identify randomized trials stopped early for ben-
efit [16]. Of 143 trials stopped early for benefit, the major-
ity (92) were published in high-impact medical journals
(New England Medical Journal, Journal of the American
Medical Association, Annals of Internal Medicine). On
average, trials recruited 63% of the planned sample and
stopped after when a median of 66 total outcome events
(experimental + control). The median relative risk reduc-
tion among truncated trials was 47%. Trials with fewer
events yielded greater treatment effects (odds ratio, 28;
95% confidence interval, 11–73).
Importance of Our Findings
If one accepts that our sample of orthopaedic randomized
trials represents small trials with implausibly large bene-
fits, then our findings are interesting and the implications
of our study highly relevant and important. The average
study in our review had a sample size of 81 patients but
reported a large beneficial treatment effect (61% relative
risk reduction). Surgeons should consider the plausibility
of the magnitude of the treatment effect because chance
effects do occur and happen more frequently than many
of us realize [15]. Statistical simulation studies have
shown that RCTs can overestimate the magnitude of the
treatment effect depending on the timing (ie, the fraction
of the total planned sample size or expected number of
events) of the decision to stop [27].
Indirect evidence for the implausibility of treatment
effects reported in small orthopaedic trauma trials with
large reported treatment benefits is available. For exam-
ple, early small randomized trials (sample sizes 48–141)
comparing reamed versus non-reamed intramedullary
Table 4: Outcome Measures Reported in 76 Trials
Continuous
Functional/Clinical Score
OR time/Surgical time/Fluoroscopy time
Blood loss
Grip strength/Power
Time to Union
Range of Motion
Radiographic Results/Scores
Days in hospital
Load to failure
Dichotomous
General complications
Reoperation
Failure
Nonunion/Union/Malunion
Pain
Infection
Mortality
Need for transfusion
Segmental Collapse/Avascular Necrosis
Parasthesia
Return to preinjured state
Return to workPage 7 of 13
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2008, 9:14 http://www.biomedcentral.com/1471-2474/9/14nailing identified relative risk reductions in nonunion
with reamed nailing of 54% (but as high as 79%) [27]. If
surgeons truly believed that reamed nails could reduce the
risk of an important adverse event by over 50%, surely
every surgeon would have adopted this relatively simple
strategy [28]. However, surveys of surgeons conducted
years after the conduct of these trials found that 42% of
surgeons continued to use the non-reamed nail [29]. It
remains plausible, then, that the surgical community
believed that 54% risk reductions were "implausibly"
high.
In another example, pooled analyses small randomized
trials have reported large reductions in the risk of reoper-
ation (74%) with plates compared to intramedullary nails
in the treatment of humeral shaft fractures [30-32]. Again,
if practicing surgeons believed these trials, they would
abandon the use of nails. This is not so. The continued use
of intramedullary nails for humeral shaft fractures sug-
gests, at least in part, possible skepticism with small trials
with large treatment effects.
Recommendations
Authors should cautiously interpret the positive findings
of studies when sample sizes of the study are small and
the total number of outcome events are few. As the
number of outcome events increases, surgeons should
have increasingly greater confidence in the reported mag-
nitude of the treatment effect. For example, a trial claim-
ing that reamed intramedullary tibial nails reduce the risk
of revision surgery by 50% in 1000 patients with 200 out-
come events is less likely influenced by the random
chance than a similar study of 100 patients with 20 out-
come events.
Wright and Gebhardt call for specialty orthopaedic socie-
ties to take action towards the conduct of multicenter ran-
Scatter plot of Total Number of Events Versus Relative Risk ReductionFig re 2
Scatter plot of Total Number of Events Versus Rela-
tive Risk Reduction. Regression lines with 95% confidence 
interval is presented. Total Number of Events = 62 – 
0.59(Relative Risk Reduction).
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Table 5: Treatment Effects and Outcome Events for Dichotomous Variables
Number Outcome Events No. Studies Relative Risk* Reduction 95% confidence Interval P Value
0–25 29 73% 67%–79%
P = 0.007
25–50 15 59% 50%–67%
P = 0.005
51–75 4 33% 15%–50%
P = 0.20
75–100 2 16% 0.01%–41%
* Represented as the mean relative risk reduction across studies
Total Number of Events Versus Treatment EffectFigure 3
Total Number of Events Versus Treatment Effect.
                                                     25%               50%                 75%              100% 
                       Relative Risk Reduction 
Total Outcome  
Events
(Treatment + 
Comparison) 
 0-25 events 
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N=29 studies 
N=15 studies 
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sufficient to enroll sufficiently large numbers of patients
efficiently.
Conclusion
Our review suggests that statistically significant results in
orthopaedic trials have the following implications-1) On
average large risk reductions are reported 2) Large treat-
ment effects (>50% relative risk reduction) are correlated
with few number of total outcome events. Readers should
interpret the results of such small trials with these issues
in mind.
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